Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study.

"B.Z. reports investigator-initiated research grants from GlaxoSmithKline Biologicals and from Takeda Pharmaceuticals outside the submitted work. No other competing interests were reported by authors. Other authors have no conflicts of interest to disclose."

"This work was partly funded by Bill & Melinda Gates Foundation [OPP1117653], a Wellcome Trust Programme Grant [WT091909/B/10/Z], the Medical Research Council, UK, and the National Institute for Health Research (NIHR) Global Health Research Unit on Mucosal Pathogens using UK aid from the UK Government [16/136/46]. The Malawi-Liverpool-Wellcome Clinical Research Programme is supported by a Strategic Award from the Wellcome Trust [206545/Z/17/Z]. The views expressed in this publication are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funders had no role in study design, collection, analysis, data interpretation, writing of the report or in the decision to submit the paper for publication. The corresponding author had full access to the study data and, together with the senior authors, had final responsibility for the decision to submit for publication."